Advertisement

Correlation of gallium-67 spect and CT findings in primary gynecologic lymphoma

      Abstract

      Primary gynecologic malignant lymphomas are rare and gallium (Ga)-67 imaging has proven to be useful to differentiate viable lymphoma from fibrotic or necrotic tissue. Computed tomographic (CT) scan is often used in initial localization and staging of the lymphoma. In this study, we retrospectively analyzed the findings of Ga-67 single photon emission computed tomography (SPECT) correlated with those of CT scan for staging initial disease and also differentiation between active lymphoma and post-treatment changes in the follow-up studies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Freeman C
        • Berg J.W
        • Culter S.J
        Occurrence and progression of extranodal lymphoma.
        Cancer. 1972; 29: 252-260
        • Edwards C.L
        • Hayes R.L
        Tumor scanning with Ga-67 citrate.
        J Nucl Med. 1969; 10: 103-105
        • Lewis E
        • Bernerdino M.E
        • Salvadoer P.G
        • et al.
        Post-therapy CT detected mass in lymphoma patients.
        J Comput Assist Tomogr. 1982; 6: 792-796
        • Israel O
        • Front D
        • Epalbaum R
        • Ben-Heim S
        • Jerushalmi J
        • Kleinhaus U
        • Even-Sapir E
        • Robinson E
        Residual mass and negative Ga-67 scintigraphy in treated lymphoma.
        J Nucl Med. 1990; 31: 365-368
      1. Non-Hodgkin’s lymphoma, Pathologic classification project: National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49(10): 2112–2135.

        • Carbone P.D
        • Kaplan H.S
        • Musshoff K
        • Smithers D.W
        • Tubiana M
        Report of the committee on Hodgkin’s disease staging classification.
        Cancer Res. 1971; 31: 1860-1861
        • Harris N.H
        • Scully R.E
        Malignant lymphoma and granulocytic sarcoma of the uterus and vagina.
        Cancer. 1984; 53: 2530-2545
        • Rosenberg S.A
        • Diamond H.D
        • Carver L.F
        Lymphosarcoma.
        Medicine. 1961; 43: 31-48
        • Monterroso V
        • Jaffe E.S
        • Merino M.J
        • Medeiros L.J
        Malignant lymphomas.
        Am J Surg Pathol. 1993; 17: 154-170
        • Komaki R
        • Cox J.D
        • Hansen R.M
        • Gunn W.G
        • Greenberg M
        Malignant lymphoma of uterine cervix.
        Cancer. 1984; 54: 1699-1704
        • Fox H
        • More J.R.S
        Primary malignant lymphoma of the uterus.
        J Clin Pathol. 1965; 18: 723-728
        • Perren T
        • Fassant M
        • McCarthy K
        • Harper P
        • Wiltshaw E
        Lymphomas of the cervix and upper vagina, a report of 5 cases of review of the literature.
        Gynecol Oncol. 1992; 44: 87-95
        • Dang H.T
        • Terk M.R
        • Colletti P.M
        • Schlaerth J.B
        • Curtin J.P
        Primary lymphoma of the cervix.
        Magn Reson Imaging. 1991; 9: 941-944
        • Kawakami S
        • Togashi K
        • Kojima Nmorikawa K
        • Mori T
        • Konishi J
        MR appearance of malignant lymphoma of uterus.
        J Comp Assis Tomogr. 1995; 19: 238-242
        • Jenkins N
        • Husband J
        • Sellars N
        • Gore M
        MRI in primary non-Hodgkin’s lymphoma of vagina associated with a uterine congenital anomaly.
        Br J Radiol. 1997; 70: 219-222
        • Gasparini M
        • Bombardieri E
        • Castellani M
        • Tondini C
        • Maffioli L
        • Devizzi L
        • Gerundini P
        Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin’s lymphoma.
        J Nucl Med. 1998; 39: 1586-1590
        • Israel O
        • Front D
        • Lam M
        • Ben-Hain S
        • Kleinhaus U
        • Ben-Shachar M
        • Robinson E
        • Kolodny G.M
        Ga-67 imaging in monitoring lymphoma response to treatment.
        Cancer. 1988; 61: 2439-2441
        • Devizzi L
        • Maffioli L
        • Bonfante V
        • Viviani S
        • Balzarini L
        • Gasparini M
        • Valagussa P
        • Bombardieri E
        • Santoro A
        • Bonadonna G
        Comparisonm of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin’s disease.
        Ann Oncol. 1997; 8: 53-56
        • Harwood S.J
        • Carroll R.G
        • Anderson M
        • Friedman B.I
        • Zangara L.M
        • Brunette A.K
        • Kline R
        SPECT gallium scanning for lymphoma and infection.
        Clin Nucl Med. 1987; 12: 694-702
        • Gasparini M
        • Balzarini L
        • Castellani M.R
        • Tess J.D.T
        • Maffioli L.S
        • Petrillo R
        • Ceglia E
        • Musumeci R
        • Buraggi G.L
        Current role of gallium scan and magnetic resonance imaging in management of mediastinal Hodgkin’s lymphoma.
        Cancer. 1993; 72: 572-582
        • Nyman R.S
        • Rehn S.M
        • Glimelius B.L.G
        • Hagberg H.E
        • Hemmingsson A.L
        • Sundstrom C.J
        Residual mediastinal masses in Hodgkin’s disease.
        Radiology. 1989; 170: 435-440
        • Okada J
        • Yoshikawa K
        • Imazaky K
        • Minoshima S
        • Uno K
        • Itami J
        • Kuyama J
        • Maruno H
        • Arimizu N
        The use of FDG PET in the detection and management of malignant lymphoma.
        J Nucl Med. 1991; 32: 686-691
        • Hoh C.K
        • Glaspy J
        • Rosen P
        • Dahlbom M
        • Lee S.J
        • Kunkel L
        • Hawkin R.A
        • Maddahi J
        • Phelps M.E
        Whole-body FDG PET imaging for staging of Hodgkin’s disease and lymphoma.
        J Nucl Med. 1997; 38: 343-348